Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Tumor lysis syndrome cost-effectiveness of therapy
Introduction
Overview
Overview
In patients with malignancies, the cost-effectiveness of administration of a singe low dose (3 mg) of rasburicase for tumor lysis syndrome prevention may be superior to the daily intravenous allopurinol.
Cost-Effectiveness of Therapy
Cost-Effectiveness of Therapy
In patients with malignancies, the cost-effectiveness of administration of a singe low dose (3 mg) of rasburicase for tumor lysis syndrome prevention may be superior to the daily intravenous allopurinol.[1]
References
References
- ↑ Patel S, Le A, Gascon S (2012). “Cost-effectiveness of rasburicase over i.v. allopurinol for treatment of tumor lysis syndrome”. Am J Health Syst Pharm. 69 (12): 1015–6. doi:10.2146/ajhp110656. PMID 22644973.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]